Astrana Health (ASTH) Financials: Revenue & Earnings
ASTH$36.69-0.25 -0.67%
$1.82B
Market Cap
44.64
P/E
26.02
Forward P/E
58
Score
Astrana Health (ASTH) Financials: Revenue & Earnings
ASTH price $36.69 -0.25 -0.67%
- Ticker
- ASTH
- Price
- $36.69
- Change
- -0.25 -0.67%
- Market cap ?
- $1.82B
- P/E ?
- 44.64
- Forward P/E ?
- 26.02
- Dividend yield ?
- 0.00%
- Beta ?
- 0.91
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Stocklytics score
- 58
- Value
- 64
- Quality
- 34
- Growth
- 75
Stocklytics score rationale: value 64, quality 34, growth 75.
Financials
| 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 44048740 | 357747410 | 519907751 | 560618000 | 370248000 | 773915000 | 1144163000 | 1386661000 | 2034540000 | 3181769000 |
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care…
Fair value
ASTH fair value $52.38. Price $36.69. Price is 30% below fair value.
Around fair value, but more expensive than usual. A larger premium than on 78% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 158.44M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.29% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 49.60M. Net debt 648.66M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | 0.46 | — | 1.02B |
| 2026-08-06 | 0.40 | 0.34 | 972.50M | 982.23M |
| 2026-05-07 | 0.30 | 0.29 | 965.10M | 949.21M |
| 2026-03-02 | 0.12 | 0.15 | 950.53M | 930.43M |
| 2025-11-06 | 0.01 | 0.47 | 956.05M | 930.47M |
| 2025-08-07 | 0.19 | 0.36 | 654.81M | 943.74M |
| 2025-05-08 | 0.14 | 0.23 | 620.39M | 630.68M |
| 2025-02-27 | -0.15 | 0.22 | 665.21M | 617.24M |
| 2024-11-07 | 0.33 | 0.32 | 478.71M | 613.01M |
| 2024-08-07 | 0.40 | 0.39 | 486.26M | 440.75M |
| 2024-05-07 | 0.31 | 0.30 | 404.36M | 413.85M |
| 2024-02-27 | 0.26 | 0.15 | 353.04M | 341.17M |
| 2023-11-07 | 0.47 | 0.27 | 348.17M | 349.49M |
| 2023-08-07 | 0.28 | 0.25 | 348.21M | 341.97M |
| 2023-05-08 | 0.31 | 0.31 | 337.24M | 318.07M |
| 2023-02-23 | -0.06 | -0.07 | 294.21M | 247.35M |
| 2022-11-03 | 0.56 | 0.32 | 317.00M | 269.60M |
| 2022-08-04 | 0.25 | 0.20 | 269.70M | 243.76M |
| 2022-05-05 | 0.31 | 0.32 | 263.26M | 225.27M |
Dividends
Yield 0.00%. Payout ratio 4.82%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 5% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-10 | Vong John | Sell | 556 | $37.55 | 20.88K |
| 2026-10-06 | Sim Brandon | Sell | 9.89K | $37.00 | 365.89K |
| 2026-10-06 | Lam Thomas S. | Sell | 2.62K | $37.00 | 97.09K |
| 2026-10-02 | Basho Chandan | Sell | 2.09K | $35.88 | 75.06K |
| 2026-09-15 | Vong John | Sell | 96 | $38.35 | 3.68K |
| 2026-09-05 | Sim Brandon | Sell | 7.16K | $38.47 | 275.56K |
| 2026-09-05 | Basho Chandan | Sell | 1.79K | $38.47 | 68.86K |
| 2026-08-31 | Kitayama Mitchell W | Sell | 8.50K | $37.09 | 315.26K |
| 2026-08-14 | Schmidt David | Buy | 20.00K | $5.00 | 100.00K |
| 2026-08-14 | Schmidt David | Sell | 20.00K | $38.59 | 771.80K |
| 2026-08-14 | Schmidt David | Sell | 20.00K | $5.00 | 100.00K |
| 2026-08-07 | Vong John | Other | 0 | — | — |
| 2026-08-07 | Sobotka Glenn | Sell | 11.79K | — | — |
| 2026-06-27 | Sim Brandon | Sell | 1.09K | $44.51 | 48.65K |
| 2026-06-10 | Schmidt David | Buy | 4.53K | — | — |
| 2026-06-10 | Mazdyasni Matthew | Buy | 4.53K | — | — |
| 2026-06-10 | Kitayama Mitchell W | Buy | 4.99K | — | — |
| 2026-06-10 | Dong Linda | Buy | 4.53K | — | — |
| 2026-06-10 | Dai, Weili | Buy | 4.53K | — | — |
| 2026-06-10 | Chiang John | Buy | 4.53K | — | — |
| 2026-05-16 | Basho Chandan | Sell | 8.15K | $38.26 | 312.01K |
| 2026-04-14 | Basho Chandan | Sell | 3.87K | $29.07 | 112.50K |
| 2026-04-06 | Lam Thomas S. | Buy | 41.67K | — | — |
| 2026-04-06 | Sim Kenneth T. | Buy | 100.00K | — | — |
| 2026-04-06 | Sim Brandon | Buy | 201.06K | — | — |
| 2026-04-02 | Basho Chandan | Sell | 2.09K | $25.05 | 52.40K |
| 2026-04-01 | Kumar Dinesh M. | Buy | 35.30K | — | — |
| 2026-04-01 | Kumar Dinesh M. | Sell | 57.98K | $24.51 | 1.42M |
| 2026-03-26 | Sobotka Glenn | Sell | 662 | $24.27 | 16.07K |
| 2026-03-05 | Lam Thomas S. | Sell | 9.27K | $25.07 | 232.30K |
| 2026-03-05 | Kumar Dinesh M. | Sell | 1.70K | $25.07 | 42.54K |
| 2026-03-05 | Basho Chandan | Sell | 1.24K | $25.07 | 31.09K |
| 2026-02-02 | Sim Brandon | Buy | 21.33K | $23.24 | 495.80K |
| 2026-02-02 | Sim Brandon | Sell | 21.33K | $23.24 | 495.80K |
| 2026-01-23 | Kumar Dinesh M. | Sell | 10.76K | $27.16 | 292.21K |
| 2026-01-13 | Schmidt David | Buy | 20.00K | $5.79 | 115.80K |
| 2026-01-13 | Schmidt David | Sell | 4.27K | $27.12 | 115.78K |
| 2026-01-13 | Schmidt David | Sell | 20.00K | $5.79 | 115.80K |
| 2026-01-01 | Kumar Dinesh M. | Sell | 5.10K | $24.81 | 126.58K |
| 2025-12-08 | Lam Thomas S. | Buy | 29.50K | $17.78 | 524.55K |
| 2025-12-08 | Lam Thomas S. | Sell | 25.87K | $22.00 | 569.05K |
| 2025-12-08 | Lam Thomas S. | Sell | 29.50K | $17.78 | 524.55K |
| 2025-11-10 | Sim Kenneth T. | Buy | 29.50K | $17.78 | 524.55K |
| 2025-11-10 | Sim Kenneth T. | Sell | 29.50K | $17.78 | 524.55K |
| 2025-11-10 | Mazdyasni Matthew | Buy | 20.00K | $18.20 | 364.00K |
| 2025-11-10 | Mazdyasni Matthew | Sell | 20.00K | $18.20 | 364.00K |
| 2025-11-07 | Kitayama Mitchell W | Buy | 12.00K | $18.20 | 218.40K |
| 2025-11-07 | Kitayama Mitchell W | Sell | 12.00K | $18.20 | 218.40K |
| 2025-11-03 | Marsh Linda | Buy | 20.00K | $18.20 | 364.00K |
| 2025-11-03 | Marsh Linda | Sell | 11.03K | $32.99 | 363.98K |
| 2025-11-03 | Marsh Linda | Sell | 20.00K | $18.20 | 364.00K |
| 2025-10-02 | Basho Chandan | Sell | 1.98K | $27.77 | 54.96K |
| 2025-09-15 | Kitayama Mitchell W | Buy | 8.00K | $18.20 | 145.60K |
| 2025-09-15 | Kitayama Mitchell W | Sell | 8.00K | $30.23 | 241.84K |
| 2025-09-15 | Kitayama Mitchell W | Sell | 5.21K | $30.23 | 157.62K |
| 2025-09-15 | Kitayama Mitchell W | Sell | 8.00K | $18.20 | 145.60K |
| 2025-09-05 | Basho Chandan | Sell | 1.69K | $29.70 | 50.31K |
| 2025-09-05 | Kumar Dinesh M. | Sell | 1.69K | $29.70 | 50.31K |
| 2025-09-02 | Schmidt David | Buy | 20.00K | $18.20 | 364.00K |
| 2025-09-02 | Schmidt David | Sell | 20.00K | $27.76 | 555.20K |
| 2025-09-02 | Schmidt David | Sell | 20.00K | $18.20 | 364.00K |
| 2025-08-13 | Chiang John | Buy | 20.00K | $18.20 | 364.00K |
| 2025-08-13 | Chiang John | Sell | 12.28K | $29.63 | 363.97K |
| 2025-08-13 | Chiang John | Sell | 20.00K | $18.20 | 364.00K |
| 2025-07-01 | Kumar Dinesh M. | Sell | 6.83K | $25.06 | 171.18K |
| 2025-06-11 | Mazdyasni Matthew | Buy | 6.45K | — | — |
| 2025-06-11 | Marsh Linda | Buy | 6.45K | — | — |
| 2025-06-11 | Kitayama Mitchell W | Buy | 6.45K | — | — |
| 2025-06-11 | Dai, Weili | Buy | 6.45K | — | — |
| 2025-06-11 | Chiang John | Buy | 6.45K | — | — |
| 2025-06-11 | Schmidt David | Buy | 6.45K | — | — |
| 2025-06-04 | Kumar Dinesh M. | Sell | 1.66K | $25.06 | 41.50K |
| 2025-05-16 | Basho Chandan | Sell | 10.04K | $27.18 | 272.75K |
| 2025-04-29 | Kumar Dinesh M. | Sell | 828 | $31.15 | 25.79K |
| 2025-04-14 | Basho Chandan | Sell | 2.68K | $34.05 | 91.36K |
| 2025-04-02 | Basho Chandan | Sell | 1.39K | $30.02 | 41.85K |
| 2025-03-26 | Sobotka Glenn | Other | 0 | — | — |
| 2025-03-26 | Sobotka Glenn | Buy | 8.27K | — | — |
| 2025-03-26 | Sobotka Glenn | Buy | 6.43K | — | — |
| 2025-03-05 | Sim Brandon | Buy | 145.64K | — | — |
| 2025-03-05 | Sim Brandon | Sell | 105.80K | $27.19 | 2.88M |
| 2025-03-05 | Basho Chandan | Buy | 26.70K | — | — |
| 2025-03-05 | Lam Thomas S. | Sell | 9.23K | $27.19 | 251.10K |
| 2025-03-05 | Kumar Dinesh M. | Buy | 26.70K | — | — |
| 2025-03-05 | Kumar Dinesh M. | Sell | 7.87K | $27.19 | 213.88K |
| 2025-02-15 | Sim Kenneth T. | Sell | 699.90K | — | — |
| 2025-02-15 | Sim Kenneth T. | Buy | 26.23K | — | — |
| 2025-02-15 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | Sell | 699.90K | — | — |
| 2025-02-15 | Lam Thomas S. | Sell | 699.90K | — | — |
| 2025-02-15 | Lam Thomas S. | Buy | 26.23K | — | — |
| 2025-01-23 | Kumar Dinesh M. | Sell | 7.21K | $37.96 | 273.69K |
| 2025-01-17 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | Sell | 300.00K | $35.17 | 10.55M |
| 2025-01-01 | Kumar Dinesh M. | Sell | 967 | $31.53 | 30.49K |
| 2024-12-10 | Kitayama Mitchell W | Sell | 5.10K | $43.09 | 219.76K |
| 2024-11-30 | Vong John | Sell | 134 | $43.25 | 5.80K |
| 2024-11-22 | Kitayama Mitchell W | Buy | 3.41K | $18.41 | 62.76K |
| 2024-11-22 | Kitayama Mitchell W | Sell | 1.49K | $42.11 | 62.74K |
| 2024-11-22 | Kitayama Mitchell W | Sell | 3.41K | $18.41 | 62.76K |
| 2024-11-19 | Chiang John | Buy | 1.51K | $18.41 | 27.89K |
| 2024-11-19 | Chiang John | Sell | 681 | $40.93 | 27.87K |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Astrana Health, Inc. (ASTH) trades at $36.69, with a market cap of $1.82B and a trailing P/E of 44.64. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 44048740 | 357747410 | 519907751 | 560618000 | 370248000 | 773915000 | 1144163000 | 1386661000 | 2034540000 | 3181769000 |
Insights · Dividends · Forecast · Financials · Learn